Chemotherapy for advanced non-small cell lung cancer in the elderly population-Reference-Cited by-同舟云学术

Chemotherapy for advanced non-small cell lung cancer in the elderly population

Published:2015-10-20 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Santos Fábio N¹,de Castria Tiago B²,Cruz Marcelo RS³,Riera Rachel⁴

Affiliation:

1. AC Camargo Cancer Center; Medical Oncology; Rua Prof. Antonio Prudente, 211 São Paulo São Paulo Brazil 01509-900

2. Instituto do Câncer do Estado de São Paulo (ICESP/FMUSP); Medical Oncology; Av. Doutor Arnaldo 251 - Cerqueira César São Paulo Brazil 01246-000

3. Beneficencia Portuguesa de São Paulo; Medical Oncology; Rua Martiniano de Carvalho 951 São Paulo São Paulo Brazil 013023001

4. Centro de Estudos de Saúde Baseada em Evidências e Avaliação Tecnológica em Saúde; Cochrane Brazil; Rua Borges Lagoa, 564 cj 63 São Paulo SP Brazil 04038-000

Publisher

Wiley

Subject

Pharmacology (medical)

Reference111 articles.

1. Randomized phase III trial comparing weekly docetaxel (D)-cisplatin (P) combination with tri weekly D alone in elderly patients (pts) with advanced non-small cell lung cancer (NSCLC): an intergroup trial of JCOG0803/WJOG4307L;Abe;Journal of Clinical Oncology,2011

2. Cisplatin plus gemcitabine versus a cisplatin-based triplet versus non platinum sequential doublets in advanced non-small cell lung cancer: a Spanish lung cancer group phase III randomized trial;Alberola;Journal of Clinical Oncology,2003

3. An ELCWP phase III trial comparing ifosfamide and cisplatin regimens in advanced NSCLC;Berghmans;Anticancer Research,2013

4. Triples versus doublets with or without cisplatin in the first-line treatment of stage IIIB, IV non-small cell lung cancer (NSCLC) patients: a multicenter randomised trial (FAST);Boni;British Journal of Cancer,2012

5. Efficacy of platinum-based regimens in non-small cell lung cancer. A negative report from the Cuneo Lung Cancer Study Group;Buccheri;Lung Cancer,1997

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. International expert consensus on diagnosis and treatment of lung cancer complicated by chronic obstructive pulmonary disease;Translational Lung Cancer Research;2023-08

2. Best first-line therapy for people with advanced non-small cell lung cancer, performance status 2 without a targetable mutation or with an unknown mutation status;Cochrane Database of Systematic Reviews;2023-07-07

3. Non-oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up;Annals of Oncology;2023-04

4. Genotoxicity and apoptotic effect of silver(I) complexes with mixed-ligands of thiosemicarbazones and diphenyl(p-tolyl)phosphine on malignant melanoma cells, SK-MEL-28;Mutation Research/Genetic Toxicology and Environmental Mutagenesis;2023-02

5. First-line treatment for lung cancer among Japanese older patients: A real-world analysis of hospital-based cancer registry data;PLOS ONE;2021-09-20